WIN-Partners Co., Ltd. (3183) AI Stock Analysis

0 Followers

WIN-Partners Co., Ltd.

(TSE/TYO:3183)

Select Model

Rating:76Outperform

Price Target:JPY 1,444.00▲(15.43% Upside)

Action:reiterated

Date:11/06/26

Strong financial performance and attractive valuation are the primary positive drivers, tempered by weak technical momentum.

Positive Factors

Consistent revenue growthSustained revenue growth across multiple years indicates continued demand for the company’s medical distribution activities. This provides a durable base for maintaining scale, supporting operating earnings, and funding future business needs even though distributor margins remain relatively modest.

Negative Factors

Thin distributor marginsLow and slightly declining margins leave limited room to absorb higher operating costs, pricing pressure, or execution setbacks. Because small changes in gross profitability can materially affect earnings for a distributor, sustained margin softness could constrain long-term profit expansion.

WIN-Partners Co., Ltd. (3183) vs. iShares MSCI Japan ETF (EWJ)

Market Cap: JPY 34.26B
Dividend Yield: 4.32%
Average Volume (3M): 29.13K
Price to Earnings (P/E): 13.8
Beta (1Y): 0.56
Revenue Growth: 13.99%
EPS Growth: 17.93%
Country: Japan
Employees: 653
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Distribution

WIN-Partners Co., Ltd. Business Overview & Revenue Model

Company Description

Established in 1973 and headquartered in Tokyo, Japan, WIN-Partners Co., Ltd. leverages its subsidiaries to distribute a comprehensive range of medical devices to healthcare institutions, primarily across Japan. Its diverse product offerings include...

WIN-Partners Co., Ltd. Financial Statement Overview

Summary

Strong balance sheet with negligible debt and consistent revenue growth, offset by cash flow volatility.

Income Statement

85Very Positive

Balance Sheet

90Very Positive

Cash Flow

70Positive

Financial statement breakdown
Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	92.28B	90.39B	81.41B	77.06B	70.85B	62.12B
Gross Profit	10.73B	10.66B	9.89B	9.53B	8.66B	7.74B
EBITDA	3.25B	3.32B	3.10B	2.92B	3.11B	2.45B
Net Income	2.04B	2.12B	2.02B	1.84B	2.05B	1.54B
Balance Sheet
Total Assets	49.63B	50.63B	46.65B	47.75B	43.91B	40.21B
Cash, Cash Equivalents and Short-Term Investments	15.00B	15.93B	16.21B	18.16B	16.77B	17.12B
Total Debt	784.33M	713.06M	0	0	0	0
Total Liabilities	27.43B	27.34B	22.58B	24.37B	21.12B	19.07B
Stockholders Equity	22.20B	23.29B	24.07B	23.39B	22.78B	21.14B
Cash Flow
Free Cash Flow	0	2.70B	1.59B	2.54B	-525.17M	673.91M
Operating Cash Flow	0	2.93B	2.06B	3.04B	445.15M	1.85B
Investing Cash Flow	0	-132.31M	-2.17B	-219.47M	1.92B	-1.28B
Financing Cash Flow	0	-3.08B	-1.83B	-1.45B	-1.16B	-947.37M

WIN-Partners Co., Ltd. Technical Analysis

Technical Analysis SentimentPositive

Last Price1251.00

Price Trends

50DMA1247.82Positive

100DMA1262.43Negative

200DMA1284.50Negative

Market Momentum

MACD-0.19Negative

RSI52.12Neutral

STOCH70.77Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3183, the sentiment is Positive. The current price of 1251.00 is above the 20-day moving average (MA) of 1235.85, above the 50-day MA of 1247.82, and below the 200-day MA of 1284.50, indicating a neutral trend. The MACD of -0.19 indicates Negative momentum. The RSI at 52.12 is Neutral, neither overbought nor oversold. The STOCH value of 70.77 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3183.

WIN-Partners Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

JP:3183 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JP:3183	76Outperform	JPY 36.09B	13.76	―	4.32%	13.99%	17.93%
JP:7071	64Neutral	JPY 36.28B	11.37	―	1.09%	6.17%	-33.01%
JP:4480	63Neutral	JPY 80.31B	42.33	12.35%	―	24.03%	34.50%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
JP:7600	42Neutral	JPY 8.37B	-5.42	―	5.41%	-8.68%	-75.03%
JP:7061	41Neutral	JPY 3.70B	11.22	―	5.73%	14.91%	-39.00%

* Healthcare Sector Average

Performance Comparison

JP:3183 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
JP:3183	WIN-Partners Co., Ltd.	1251.00	9.17	0.74%
JP:4480	Medley, Inc.	2595.00	318.00	13.97%
JP:7061	Japan Hospice Holdings Inc.	436.00	-920.19	-67.85%
JP:7071	Amvis Holdings.Inc.	368.00	-115.07	-23.82%
JP:7600	Japan Medical Dynamic Marketing, Inc.	314.00	-174.23	-35.69%

WIN-Partners Co., Ltd. Corporate Events

WIN-Partners Reports Strong First-Half Sales and Profit Growth

Nov 4, 2026

WIN-Partners Co., Ltd. reported strong consolidated results for the six months ended September 30, 2026, with net sales rising 18.0% year on year to ¥51.6 billion, operating profit increasing 40.9% to ¥2.1 billion, and profit attributable to owners o...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 06, 2026

WIN-Partners Co., Ltd. AI Stock Analysis